Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 5, 2003, Pages 490-499

  Pubill, David ^a   Canudas, Anna M ^a   Pallàs, Mercè ^a   Camins, Antonio ^a   Camarasa, Jorge ^a   Escubedo, Elena ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ecstasy; Glial activation; HSP27; MDMA; Methamphetamine; Neurotoxicity; Peripheral type benzodiazepine receptor

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BENZODIAZEPINE RECEPTOR; HEAT SHOCK PROTEIN 27; METHAMPHETAMINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG MECHANISM; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROTOXICITY; NONHUMAN; RAT; RECEPTOR DENSITY; RECTUM TEMPERATURE; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; THERMOREGULATION; TIME SERIES ANALYSIS;

ANIMALS; BINDING SITES; BODY WEIGHT; BRAIN; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG ADMINISTRATION SCHEDULE; FEVER; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT-SHOCK PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TIME FACTORS;

EID: 0038796835     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0747-y     Document Type: Article

References (48)

1. Ali SF, Newport GD, Holson RR, Slikker W Jr, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38
2. Battaglia G, Yeh SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274
3. Baulieu EE (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987
4. Benavides J, Fage D, Carter C, Scatton B (1987) Peripheral type benzodiazepine binding sites are a sensitive indirect marker of neuronal damage. Brain Res 421:167-172
5. Biegon A, Alvarado M, Budinger TF, Grossman R, Hensley K, West MS, Kotake Y, Ono M, Floyd RA (2002) Region-selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. J Neurochem 82:924-934
6. Blundell JE, Leshem MB (1973) Dissociation of the anorexic effects of fenfluramine and amphetamine following intrahypothalamic injection. Br J Pharmacol 47:183-185
7. 3H]dopamine from striatal slices. J Pharmacol Exp Ther 257:262-270
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
9. Casellas P, Galiegue S, Basile A (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40:475-486
10. Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR (2001) A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurones in mouse brain. Br J Pharmacol 134:1711-1723
11. Currie RW, Ellison JA, White RF, Feuerstein GZ, Wang X, Barone FC (2000) Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res 863:169-181
12. Del Cerro S, Garcia-Estrada J, Garcia-Segura LM (1995) Neuroactive steroids regulate astroglia morphology in hippocampal cultures from adult rats. Glia 14:65-71
13. Eddlestone M, Mucke L (1993) Molecular profile of reactive astrocyte-implications for their role in neurologic disease. Neuroscience 54:15-36
14. Eisch AJ, Gaffney M, Weihmuller FB, O'Dell ST, Marshall JF (1992) Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 598:321-326
15. Ellison G, Eison MS, Huberman HS, Daniel F (1978) Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201:276-278
16. Escubedo E, Guitart L, Sureda FX, Jiménez A, Pubill D, Pallàs M, Camins A, Camarasa J (1998) Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats. Brain Res 814:120-126
17. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838
18. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann KA, Kreutzberg GW (1992) Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 12:257-269
19. Kato H, Liu Y, Kogure K, Kato K (1994) Induction of 27-kDa heat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res 634:235-244
20. Kogan FJ, Nichols WK, Gibb JW (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363-371
21. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Pharmacol Sci 19:312-318
22. Kuhlmann AC, Guilarte TR (2000) Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin. J Neurochem 74:1694-1704
23. Lacor P, Gandolfo P, Tonon MC, Brault E, Dalibert I, Schumacher M, Benavides J, Ferzaz B (1999) Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res 815:70-80
24. Logan BJ, Laverty R, Sanderson WD, Yee YB (1988) Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 152:227-234
25. Mechan AO, O'Shea E, Elliott JM, Colado MI, Green AR (2001) A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation. Psychopharmacology 155:413-418
26. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
27. O'Callaghan JP, Miller DB (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751
28. O'Dell SJ, Weihmuller FB, Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256-260
29. Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Gamier M, Hardwick M, Li H, Vidic B, Brown AS, Reversa JL, Bernassau JM, Drieu K (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62:21-28
30. Park CH, Carboni E, Wood PL, Gee KW (1996) Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16:65-70
31. Plumier JCL, Armstrong JN, Landry J, Babity JM, Robertson HA, Currie RW (1996) Expression of the 27,000 mol. wt heat shock protein following kainic acid-induced status epilepticus in the rat. Neuroscience 75:849-856
32. Pu C, Vorhees CV (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Dev Brain Res 72:325-328
33. Renkawek K, Bossman GJCGM, Jong WW de (1994) Expression of small heat-shock protein hsp27 in reactive gliosis in Alzheimer disease and other type of dementia. Acta Neuropathol 87:511-519
34. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res 235:93-103
35. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME (1988) (±)3,4-Methylenedioxymethamphetamine (MDMA) selectively damages central serotonergic neurons in non-human primates. JAMA 260:51-55
36. Ricaurte GA, Yuan J, McCann UD (2000) (±)3,4-Methylenedioxymethamphetamine ("Ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10
37. Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("Ecstasy"). Science 297:2260-2263
38. Rudge JS (1993) Astrocyte-derived neurotrophic factors. In: Murphy S (ed) Astrocytes: pharmacology and function. Academic Press, San Diego, pp 267-305
39. Samanin R, Garattini S (1993) Neurochemical mechanism of action of anorectic drugs. Pharmacol Toxicol 73:63-68
40. Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA (1993) Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264:1484-91
41. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398-400
42. Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6:557-618
43. Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR, Clemens JA (1995) Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15:5263-5274
44. Streit WJ, Graeber MB (1993) Heterogeneity of microglial and perivascular cell populations: insights gained from the facial nucleus paradigm. Glia 7:68-74
45. Veenman L, Gavish M (2000) Peripheral-type benzodiazepine receptors: their implications in brain disease. Drug Dev Res 50:355-370
46. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP (1997) PK binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50:345-353
47. White SR, Obradovic T, Imel KM, Wheaton MJ (1996) The effects of methylenedioxymethamphetamine (MDMA, ecstasy) on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 62:41-50
48. Xiao BG, Link H (1998) Immune regulation within the central nervous system. J Neurol Sci 157:1-12